Lieza G Exalto1, Geert Jan Biessels2, Andrew J Karter3, Elbert S Huang4, Wayne J Katon5, Jerome R Minkoff6, Rachel A Whitmer7. 1. Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands; Kaiser Permanente Division of Research, Oakland, CA, USA. 2. Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands. 3. Kaiser Permanente Division of Research, Oakland, CA, USA. 4. Department of Internal Medicine, University of Chicago, Chicago, IL, USA. 5. Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA. 6. Kaiser Permanente, Department of Endocrinology, Santa Rosa, CA, USA. 7. Kaiser Permanente Division of Research, Oakland, CA, USA. Electronic address: rachel.whitmer@kp.org.
Abstract
BACKGROUND: Although patients with type 2 diabetes are twice as likely to develop dementia as those without this disease, prediction of who has the highest future risk is difficult. We therefore created and validated a practical summary risk score that can be used to provide an estimate of the 10 year dementia risk for individuals with type 2 diabetes. METHODS: Using data from two longitudinal cohorts of patients with type 2 diabetes (aged ≥60 years) with 10 years of follow-up, we created (n=29,961) and validated (n=2413) the risk score. We built our prediction model by evaluating 45 candidate predictors using Cox proportional hazard models and developed a point system for the risk score based on the size of the predictor's β coefficient. Model prediction was tested by discrimination and calibration methods. Dementia risk per sum score was calculated with Kaplan-Meier estimates. FINDINGS: Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic events, depression, age, and education were most strongly predictive of dementia and constituted the risk score (C statistic 0·736 for creation cohort and 0·746 for validation cohort). The dementia risk was 5·3% (95% CI 4·2-6·3) for the lowest score (-1) and 73·3% (64·8-81·8) for the highest (12-19) sum scores. INTERPRETATION: To the best of our knowledge, this is the first risk score for the prediction of 10 year dementia risk in patients with type 2 diabetes mellitus. The risk score can be used to increase vigilance for cognitive deterioration and for selection of high-risk patients for participation in clinical trials. FUNDING: Kaiser Permanente Community Benefit, National Institute of Health, Utrecht University, ZonMw, and Fulbright.
BACKGROUND: Although patients with type 2 diabetes are twice as likely to develop dementia as those without this disease, prediction of who has the highest future risk is difficult. We therefore created and validated a practical summary risk score that can be used to provide an estimate of the 10 year dementia risk for individuals with type 2 diabetes. METHODS: Using data from two longitudinal cohorts of patients with type 2 diabetes (aged ≥60 years) with 10 years of follow-up, we created (n=29,961) and validated (n=2413) the risk score. We built our prediction model by evaluating 45 candidate predictors using Cox proportional hazard models and developed a point system for the risk score based on the size of the predictor's β coefficient. Model prediction was tested by discrimination and calibration methods. Dementia risk per sum score was calculated with Kaplan-Meier estimates. FINDINGS:Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic events, depression, age, and education were most strongly predictive of dementia and constituted the risk score (C statistic 0·736 for creation cohort and 0·746 for validation cohort). The dementia risk was 5·3% (95% CI 4·2-6·3) for the lowest score (-1) and 73·3% (64·8-81·8) for the highest (12-19) sum scores. INTERPRETATION: To the best of our knowledge, this is the first risk score for the prediction of 10 year dementia risk in patients with type 2 diabetes mellitus. The risk score can be used to increase vigilance for cognitive deterioration and for selection of high-risk patients for participation in clinical trials. FUNDING: Kaiser Permanente Community Benefit, National Institute of Health, Utrecht University, ZonMw, and Fulbright.
Authors: Niraj M Parikh; Robert O Morgan; Mark E Kunik; Hua Chen; Rajender R Aparasu; Ravi K Yadav; Paul E Schulz; Michael L Johnson Journal: Int J Geriatr Psychiatry Date: 2010-10-04 Impact factor: 3.485
Authors: Howard H Moffet; Nancy Adler; Dean Schillinger; Ameena T Ahmed; Barbara Laraia; Joe V Selby; Romain Neugebauer; Jennifer Y Liu; Melissa M Parker; Margaret Warton; Andrew J Karter Journal: Int J Epidemiol Date: 2008-03-07 Impact factor: 7.196
Authors: Frank Jessen; Birgitt Wiese; Horst Bickel; Sandra Eiffländer-Gorfer; Angela Fuchs; Hanna Kaduszkiewicz; Mirjam Köhler; Tobias Luck; Edelgard Mösch; Michael Pentzek; Steffi G Riedel-Heller; Michael Wagner; Siegfried Weyerer; Wolfgang Maier; Hendrik van den Bussche Journal: PLoS One Date: 2011-02-18 Impact factor: 3.240
Authors: Fumiko Irie; Annette L Fitzpatrick; Oscar L Lopez; Lewis H Kuller; Rita Peila; Anne B Newman; Lenore J Launer Journal: Arch Neurol Date: 2008-01
Authors: Wayne J Katon; Elizabeth H B Lin; Lisa H Williams; Paul Ciechanowski; Susan R Heckbert; Evette Ludman; Carolyn Rutter; Paul K Crane; Malia Oliver; Michael Von Korff Journal: J Gen Intern Med Date: 2010-01-28 Impact factor: 5.128
Authors: Helen L Lutgers; Esther G Gerrits; Wim J Sluiter; Lielith J Ubink-Veltmaat; Gijs W D Landman; Thera P Links; Reinold O B Gans; Andries J Smit; Henk J G Bilo Journal: PLoS One Date: 2009-08-28 Impact factor: 3.240
Authors: Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer Journal: Alzheimers Dement Date: 2016-02-11 Impact factor: 21.566
Authors: Elizabeth R Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer Journal: Alzheimer Dis Assoc Disord Date: 2017 Jul-Sep Impact factor: 2.703
Authors: Paola Gilsanz; Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer Journal: JAMA Neurol Date: 2017-09-01 Impact factor: 18.302
Authors: Cecilia S Lee; Eric B Larson; Laura E Gibbons; Aaron Y Lee; Susan M McCurry; James D Bowen; Wayne C McCormick; Paul K Crane Journal: Alzheimers Dement Date: 2018-08-08 Impact factor: 21.566